FRED Registry Study

• Research type

  Research Study

• Full title

  Safety and efficacy analysis of FRED™/FRED™ Jr embolic device in aneurysm treatment

• IRAS ID

  223736

• Contact name

  Laurence Bousquet

• Contact email

  laurence.bousquet@microvention.com

• Sponsor organisation

  Microvention

• Duration of Study in the UK

  3 years, 0 months, 1 days

• Research summary

  This project will be observational in nature, collecting both retrospective and prospective data, regarding patient treatment and safety information with the FRED Device. Patients will be asked to participate in standardized clinical outcomes we ask that the patients consent to using their data for a post market registry study.

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  17/EM/0241

• Date of REC Opinion

  14 Jul 2017

• REC opinion

  Further Information Favourable Opinion